Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry

Abstract

Tofacitinib is effective and safe in UC patients in real practice, even in a highly refractory cohort. A relevant proportion of patients discontinue the drug over time, mainly due to primary failure.